BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20232331)

  • 41. New pentacyclic triterpenes from Gypsophila oldhamiana and their biological evaluation as glycogen phosphorylase inhibitors.
    Luo JG; Liu J; Kong LY
    Chem Biodivers; 2008 May; 5(5):751-7. PubMed ID: 18493961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and structure-activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase a.
    Li YH; Coppo FT; Evans KA; Graybill TL; Patel M; Gale J; Li H; Tavares F; Thomson SA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5892-6. PubMed ID: 16942879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
    Kristiansen M; Andersen B; Iversen LF; Westergaard N
    J Med Chem; 2004 Jul; 47(14):3537-45. PubMed ID: 15214781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of 1,2,3-triazoles from xylosyl and 5-thioxylosyl azides: evaluation of the xylose scaffold for the design of potential glycogen phosphorylase inhibitors.
    Goyard D; Baron M; Skourti PV; Chajistamatiou AS; Docsa T; Gergely P; Chrysina ED; Praly JP; Vidal S
    Carbohydr Res; 2012 Dec; 364():28-40. PubMed ID: 23147043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors.
    Galal SA; Khattab M; Andreadaki F; Chrysina ED; Praly JP; Ragab FAF; El Diwani HI
    Bioorg Med Chem; 2016 Nov; 24(21):5423-5430. PubMed ID: 27624527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and glycogen phosphorylase inhibitor activity of functionalized 1,4-benzodioxanes.
    Czakó Z; Docsa T; Gergely P; Juhász L; Antus S
    Pharmazie; 2010 Apr; 65(4):235-8. PubMed ID: 20432616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. I. Taxonomy, fermentation, isolation and biological activities.
    Furukawa S; Tsurumi Y; Murakami K; Nakanishi T; Ohsumi K; Hashimoto M; Nishikawa M; Takase S; Nakayama O; Hino M
    J Antibiot (Tokyo); 2005 Aug; 58(8):497-502. PubMed ID: 16266120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.
    Nagy V; Felföldi N; Kónya B; Praly JP; Docsa T; Gergely P; Chrysina ED; Tiraidis C; Kosmopoulou MN; Alexacou KM; Konstantakaki M; Leonidas DD; Zographos SE; Oikonomakos NG; Kozmon S; Tvaroška I; Somsák L
    Bioorg Med Chem; 2012 Mar; 20(5):1801-16. PubMed ID: 22325154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, and urease inhibition studies of some 1,3,4-oxadiazoles and 1,2,4-triazoles derived from mandelic acid.
    Akhtar T; Hameed S; Khan KM; Khan A; Choudhary MI
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):572-6. PubMed ID: 20235688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthetic studies in butenonyl C-glycosides: Preparation of polyfunctional alkanonyl glycosides and their enzyme inhibitory activity.
    Bisht SS; Fatima S; Tamrakar AK; Rahuja N; Jaiswal N; Srivastava AK; Tripathi RP
    Bioorg Med Chem Lett; 2009 May; 19(10):2699-703. PubMed ID: 19362832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling aided design of potent glycogen phosphorylase inhibitors.
    Deng Q; Lu Z; Bohn J; Ellsworth KP; Myers RW; Geissler WM; Harris G; Willoughby CA; Chapman K; McKeever B; Mosley R
    J Mol Graph Model; 2005 Apr; 23(5):457-64. PubMed ID: 15781188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C-(2-Deoxy-d-arabino-hex-1-enopyranosyl)-oxadiazoles: synthesis of possible isomers and their evaluation as glycogen phosphorylase inhibitors.
    Bokor É; Szennyes E; Csupász T; Tóth N; Docsa T; Gergely P; Somsák L
    Carbohydr Res; 2015 Aug; 412():71-9. PubMed ID: 26082971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and evaluation of several oleanolic acid glycoconjugates as protein tyrosine phosphatase 1B inhibitors.
    Liu Q; Guo T; Li D; Li F; Li W
    Eur J Med Chem; 2014 May; 79():34-46. PubMed ID: 24721313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
    Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
    Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.
    Habash M; Taha MO
    Bioorg Med Chem; 2011 Aug; 19(16):4746-71. PubMed ID: 21788139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase.
    Pardin C; Roy I; Lubell WD; Keillor JW
    Chem Biol Drug Des; 2008 Sep; 72(3):189-96. PubMed ID: 18715232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
    Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The glycogen phosphorylase inhibitor 2-(3-benzylamino-2-oxo-1,2-dihydropyridin-1-yl)-N-(3,4-dichlorobenzyl)acetamide.
    Popova I; Healy PC; Loughlin WA; Karis ND; Jenkins ID
    Acta Crystallogr C; 2013 Nov; 69(Pt 11):1408-10. PubMed ID: 24192198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases.
    Wen X; Sun H; Liu J; Wu G; Zhang L; Wu X; Ni P
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4944-8. PubMed ID: 16169219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanomolar Inhibitors of Glycogen Phosphorylase Based on β-d-Glucosaminyl Heterocycles: A Combined Synthetic, Enzyme Kinetic, and Protein Crystallography Study.
    Bokor É; Kyriakis E; Solovou TGA; Koppány C; Kantsadi AL; Szabó KE; Szakács A; Stravodimos GA; Docsa T; Skamnaki VT; Zographos SE; Gergely P; Leonidas DD; Somsák L
    J Med Chem; 2017 Nov; 60(22):9251-9262. PubMed ID: 28925695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.